Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects w/ AILD
Condition(s):Acute Alcoholic HepatitisLast Updated:January 25, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Acute Alcoholic HepatitisLast Updated:January 25, 2019Terminated
Condition(s):Cirrhosis; End Stage Liver Disease; Acute Kidney Injury; Liver Transplant; Complications; Chronic Kidney Diseases; Hepatitis c; Hepatitis B; NASH – Nonalcoholic Steatohepatitis; Alcoholic Cirrhosis; Hepatocellular CarcinomaLast Updated:December 27, 2023Terminated
Condition(s):Alcoholic CirrhosisLast Updated:March 21, 2024Recruiting
Condition(s):Compensated Advanced Chronic Liver Disease; Variceal HemorrhageLast Updated:April 25, 2023Recruiting
Condition(s):Alcohol-related Liver Disease; Alcohol Dependence; Alcohol Withdrawal; Addiction, AlcoholLast Updated:May 10, 2021Unknown status
Condition(s):Hepatitis, AlcoholicLast Updated:January 27, 2020Completed
Condition(s):Chronic Liver DiseaseLast Updated:December 1, 2015Unknown status
Condition(s):Acute Alcoholic Hepatitis; Chemical and Drug Induced Liver Injury; Alcohol-Induced Disorders; Steatohepatitis Caused by Ingestible AlcoholLast Updated:April 20, 2023Recruiting
Condition(s):Human Immunodeficiency Virus; HBV; Fibrosis, Liver; Cirrhosis, Liver; Hepatocellular Carcinoma; Hepatitis Delta Virus; Alcoholic HepatitisLast Updated:July 3, 2023Active, not recruiting
Condition(s):Severe Acute Decompensated Alcoholic HepatitisLast Updated:July 29, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.